Chandrasekaran SOWRIRAJAN, Sameena YOUSUF, Muthu Vijayan Enoch İsrael VIJAYARAJ

Binding of flavanone with b-CD/ctDNA: a spectroscopic investigation

The inclusion complexation of flavanone with b-cyclodextrin was studied by ultraviolet absorption, steady state fluorescence, time-resolved fluorescence, and 2D ROESY nuclear magnetic resonance spectroscopic techniques. A 1:1 stoichiometric ratio was determined for the inclusion of flavanone with b-cyclodextrin. The Stern--Volmer constant for the accessible fraction of the binding of flavanone with b-cyclodextrin, and the binding constant for the flavanone--b-cyclodextrin complex are reported. The flavanone--b-cyclodextrin inclusion complex was characterized by 2D ROESY NMR spectroscopy. The binding of flavanone with ctDNA and the effect of b-cyclodextrin on the binding of flavanone to ctDNA were studied by absorption and fluorescence techniques. Binding constants are reported for the binding of flavanone with ctDNA and flavanone--b-cyclodextrin with ctDNA. The mode of binding of flavanone to DNA and formation of inclusion complex with b-cyclodextrin are proposed, supported by molecular modeling. The studies imply that b-cyclodextrin acts as carrier of flavanone for binding with DNA.

Anahtar Kelimeler:

Flavanone, b-cyclodextrin, fluorescence, ctDNA binding, 2D ROESY

Binding of flavanone with b-CD/ctDNA: a spectroscopic investigation

Keywords:

Flavanone, b-cyclodextrin, fluorescence, ctDNA binding, 2D ROESY,

PDF

___

1. Shen, X.; Belletete, M.; Durocher, G. J . Phys. Chem. B.1997, 101, 8212–8220.
2. Bender, M. L.; Komiyama, M. In Cyclodextrin Chemistry; Springer–Verlag: New York, NY, USA, 1978.
3. Saenger, W. Angew. Chem., Int. Ed. Engl. 1980, 19, 344–362. 4. Szejtli, J. In Cyclodextrins and Their Inclusion Complexes; Akademiai Kiado: Budapest, Hungary, 1982.
5. Li, S.; Purdy, W. C. Chem. Rev. 1992, 92, 1457–1470.
6. Szejtli, J. In Cyclodextrin Technology; Kluwer Academic Publishers: Dordrecht, Germany, 1988.
7. Yousuf, S.; Enoch I. V. M. V. AAPS Pharm. Sci. Tech. 2013, 14, 770–781.
8. Brewster, M. E.; Vandecruys, R.; Verreck, G.; Noppe, M.; Peeters, J. J. Incl. Phenom. Macro. Chem. 2002, 44, 35–38.
9. Enoch, I. V. M. V.; Yousuf, S. J. Solution Chem. 2013, 42, 470–484.
10. Stefansson, E.; Loftssonn, T. J. Incl. Phenom. Macro. Chem. 2002, 44, 23–27.
11. Boumendjel, A.; Ronot, X.; Boutonnat, J. Curr. Drug Targets, 2009, 10, 363–371.
12. Ducki, S. Anticancer Agents Med. Chem. 2009, 9, 336–347.
13. Kontogiorgis, C.; Mantzanidou, M.; Hadjipavlou-Litina, D. Mini. Rev. Med. Chem. 2008, 8, 1224–1242.
14. Tomar, V.; Bhattacharjee, G.; Kamaluddin, S.; Srivastava, R. K.; Puri, S. K. Eur. J. Med. Chem. 2010, 45, 745–751.
15. Mojzis, J.; Varinska, L.; Mojzisova, G.; Kostova, I.; Mirossay, L. Pharmacol. Res. 2008, 57, 259–265.
16. Sivakumar, P. M.; Priya, S.; Doble, M. Chem. Biol. Drug. Des. 2009, 73, 403–415.
17. Halfon, B.; Ciftci, E.; Topcu, G. Turk. J. Chem. 2013, 37, 464–472.
18. Pouget, C.; Lauthier F.; Simon, A.; Fagnere, C.; Basly, J. -P.; Delage, C.; Chulia, A. -J. Bio-org. Med. Chem. Lett. 2001, 11, 3095–3097.
19. Qu, X.; Ren, J.; Riccelli, P. V.; Benight, R.; Chaives, J. B. Biochem. 2003, 42, 11960–11967.
20. Pindur, U.; Jansen, M.; Lemster, T. Curr. Med. Chem. 2005, 12, 2805–2847.
21. Lakowicz, J. R. In Principles of Fluorescence Spectroscopy, 3rd ed., Springer, Singapore, 2000.
22. Panda, D.; Khatua, S.; Datta, A. J. Phys. Chem. B 2007, 111, 1648–1656.
23. Ibrahim, M. S.; Shehatta, I. S.; Al-Nayeli, A. A.; J. Pharm. Biomed. Anal. 2002, 28, 217–225.
24. Frezza, M.; Dou, Q. P.; Xiao, Y.; Samouei, H.; Rashidi, M.; Samari, F.; Hemmateenejad, B. J. Med. Chem. 2011, 54, 6166–6176.
25. Sameena, Y.; Enoch, I. V. M. V. J. Lumin. 2013, 138, 105–116.
26. Yan, L.; Ke, G.; Lv, J.; Gui S. Z., Qing, F. L. J. Fluoresc. 2011, 21, 409–414.
27. Bernstein, H. J. RasMol 2.7.5.2. Molecular graphics visualization tool. Based on RasMol 2.6 by Roger Sayle Biomolecular structures group. Stevenage, Hertfordshire, UK: Glaxo Welcome Research & Development, 2011.